Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EARS

Auris Medical

$0.40

-0.0022 (-0.55%)

08:46
01/23/19
01/23
08:46
01/23/19
08:46
Hot Stocks
Auris Medical announces publication of betahistine data in neuroscience journal »

Auris Medical highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
EARS

Auris Medical

$0.43

0.0058 (1.36%)

08:52
01/15/19
01/15
08:52
01/15/19
08:52
Hot Stocks
Auris Medical provides update on intranasal betahistine development programs »

Auris Medical provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
EARS

Auris Medical

$0.55

-0.0378 (-6.42%)

07:53
12/06/18
12/06
07:53
12/06/18
07:53
Hot Stocks
Auris Medical acquires orphan drug designation for betahistine, two patents »

Auris Medical announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EARS

Auris Medical

$0.60

0.02 (3.45%)

09:15
11/30/18
11/30
09:15
11/30/18
09:15
Syndicate
Auris Medical enters into $3.25M equity sales agreement with A.G.P. »

Auris Medical entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EARS

Auris Medical

$0.69

-0.015 (-2.14%)

09:21
11/27/18
11/27
09:21
11/27/18
09:21
Hot Stocks
Auris Medical says FiveT committs to subscribe for 1.615M common shares »

Auris Medical disclosed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EARS

Auris Medical

$0.51

-0.0208 (-3.92%)

09:30
11/20/18
11/20
09:30
11/20/18
09:30
Hot Stocks
Auris Medical announces results of pre-IND meeting with FDA for AM-201 »

Auris Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EARS

Auris Medical

$0.95

0.31 (48.25%)

16:59
11/01/18
11/01
16:59
11/01/18
16:59
Syndicate
Breaking Syndicate news story on Auris Medical »

Auris Medical files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EARS

Auris Medical

$0.95

0.31 (48.25%)

16:59
11/01/18
11/01
16:59
11/01/18
16:59
Syndicate
Breaking Syndicate news story on Auris Medical »

Auris Medical files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
EARS

Auris Medical

$1.47

0.06 (4.26%)

07:55
10/17/18
10/17
07:55
10/17/18
07:55
Conference/Events
Auris Medical to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

EARS

Auris Medical

$1.47

0.06 (4.26%)

06:51
10/17/18
10/17
06:51
10/17/18
06:51
Hot Stocks
Auris Medical reports Phase 1 clinical trial results for intranasal betahistine »

Auris Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.